Suzlon Energy wins 21 MW order from Serum Institute of India

22 Jun 2012 Evaluate

Suzlon Energy has bagged 21 MW order from a biotech major - Serum Institute of India. The order is to supply 10 turbines of 2.1 MW capacity each for captive consumption. As per the agreement, the company will supply, set up, operate and maintain the S88 wind turbines for Serum Institute in Pune.

Serum Institute of India is a leading biotech company and among the world's largest makers of pediatric vaccines as well as of measles and DTP group of vaccines. After awarding the contract the total renewable energy portfolio of the biotech company will increase to 60 MW.

Suzlon Group comprises of Suzlon Energy and its subsidiaries, including REpower Systems SE. Suzlon Energy is leader in wind energy in the India, which is world’s fifth largest wind energy market. Its business model has range of services that include development, manufacturing, marketing, EPC project delivery and operations and maintenance of wind turbine generators around the world.

Suzlon Energy Share Price

52.65 -0.49 (-0.92%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Havells India 1411.30
Siemens 3161.60
Apar Inds 8939.85
Waaree Energies 2918.70
ABB India 5239.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×